- Home
- AIRS vs SMTI Comparison
AIRS vs SMTI Comparison
Compare AIRS & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRS
- SMTI
- Stock Information
- Founded
- AIRS 2012
- SMTI 1982
- Country
- AIRS United States
- SMTI United States
- Employees
- AIRS N/A
- SMTI N/A
- Industry
- AIRS Medical/Nursing Services
- SMTI Medical/Dental Instruments
- Sector
- AIRS Health Care
- SMTI Health Care
- Exchange
- AIRS Nasdaq
- SMTI Nasdaq
- Market Cap
- AIRS 400.5M
- SMTI 288.2M
- IPO Year
- AIRS 2021
- SMTI N/A
- Fundamental
- Price
- AIRS $5.35
- SMTI $33.01
- Analyst Decision
- AIRS Hold
- SMTI Buy
- Analyst Count
- AIRS 2
- SMTI 1
- Target Price
- AIRS $5.00
- SMTI $44.00
- AVG Volume (30 Days)
- AIRS 248.7K
- SMTI 36.4K
- Earning Date
- AIRS 11-08-2024
- SMTI 11-12-2024
- Dividend Yield
- AIRS N/A
- SMTI N/A
- EPS Growth
- AIRS N/A
- SMTI N/A
- EPS
- AIRS N/A
- SMTI N/A
- Revenue
- AIRS $188,780,000.00
- SMTI $78,056,873.00
- Revenue This Year
- AIRS N/A
- SMTI $29.95
- Revenue Next Year
- AIRS $10.31
- SMTI $19.68
- P/E Ratio
- AIRS N/A
- SMTI N/A
- Revenue Growth
- AIRS N/A
- SMTI 24.66
- 52 Week Low
- AIRS $2.92
- SMTI $26.00
- 52 Week High
- AIRS $9.20
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- AIRS 38.88
- SMTI 34.95
- Support Level
- AIRS $5.58
- SMTI $31.13
- Resistance Level
- AIRS $6.60
- SMTI $34.22
- Average True Range (ATR)
- AIRS 0.58
- SMTI 1.80
- MACD
- AIRS -0.15
- SMTI -0.63
- Stochastic Oscillator
- AIRS 0.43
- SMTI 12.98
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.